Endo Sees Strong Prospects For Hybrid Injectables Pipeline

Syringes
Endo is lining up a pipeline of differentiated injectables via the US 505(b)(2) regulatory pathway • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Value Added Medicines

More from Products